Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068861 · ClinicalTrials.gov registry record · Phase 3
Treatment of Infertility in Women With Polycystic Ovary Syndrome
A Phase 3 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 3
- Development phase
- 678
- Enrollment target
NCT00068861 is a Phase 3 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 678 participants.
The verdict
NCT00068861, a Phase 3 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 678 participants
- Enrollment target
Study Summary
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.
Interventions
- DRUG metformin XR
- DRUG clomiphene citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-02 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068861
The ClinicalTrials.gov registry entry for NCT00068861 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which metformin XR is the first listed.
NCT00068861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068861 about?
NCT00068861 is a clinical study titled "Treatment of Infertility in Women With Polycystic Ovary Syndrome". Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which work...
What is the current status of trial NCT00068861?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 678 participants. The study started on 2002-11. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00068861?
The interventions under investigation include: metformin XR (DRUG), clomiphene citrate (DRUG).
Who is sponsoring clinical trial NCT00068861?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.